Navigation Links
First national study of diving-related injuries
Date:8/3/2008

ed a flip, handstand or backward dive.

"There is a need for increased prevention efforts to lower the risks of diving-related injuries among children and adolescents," explained study co-author Lara McKenzie, PhD, MA, principal investigator in CIRP at Nationwide Children's Hospital. "The recent growth of the sport of diving, coupled with the increasing complexity and difficulty of dives, has resulted in a greater potential for both competitive and recreational diving-related injuries."

"Based on our findings, the largest age group of injured divers was 10- to 14 year-olds," said study co-author Gary Smith, MD, DrPH, director of the Center for Injury Research and Policy at Nationwide Children's Hospital, and an associate professor of pediatrics at The Ohio State University College of Medicine. "Although this group made up the largest number of injured divers, 10- to 19-years-olds were more at risk for an injury to the extremities. Boys were two times more likely to experience a head or neck injury or a fracture."

Recommended strategies for preventing diving-related injuries include educating divers about jumping into shallow water from the pool edge; placing visible depth indicators around the pool; constructing soft bottom pools; and removing obstacles from lakes, rivers and oceans. Also, the presence of a lifeguard or trainer, as well as teaching proper diving techniques could reduce the overall number of diving-related injuries. "Parents, pediatricians, coaches, lifeguards and trainers need to be aware of the types of injuries seen during recreational and competitive diving, as well as the risk factors," said McKenzie, also an assistant professor at The Ohio State University College of Medicine.


'/>"/>

Contact: Marti Leitch
mleitch@mediasourcetv.com
614-932-9950
Nationwide Children's Hospital
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Handa Pharmaceuticals Announces Submission of its First-to-File ANDA for AstraZenecas SEROQUEL(R) XR
2. Sweden to Receive Scandinavia's First TomoTherapy System : Lund University Hospital to Offer Swedish Cancer Patients the Most Advanced Image-Guided Radiation Therapy Treatments
3. Trubion Pharmaceuticals Provides Announcement Dates for Second Quarter and First Six Months Earnings Conference Call
4. Chindex International to Report Fiscal 2009 First Quarter Financial Results
5. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 First Quarter Financial Results
6. Safe Pesticides Now First in Poisonings
7. Encision Reports First Fiscal Quarter Results
8. MTBC First Medical Billing Company in the U.S. To Offer Automated Real-time Adjudication of Claims
9. STERIS Corporation Announces Fiscal 2009 First Quarter Results
10. FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008
11. Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First national study of diving-related injuries
First national study of diving-related injuries
(Date:12/6/2009)... A new study by researchers from the Medical College ... hydroxyurea utilization for pain and other sickle cell disease ... part of both providers and patients were also identified. ... MS, assistant professor of pediatrics at the Medical College ... Wisconsin, will be presented at the American Society of ...
(Date:12/6/2009)... ORLEANS, Dec. 6 Sickle cell disease, ... blood cells, is one of the most common ... the world, including more than 70,000 Americans.(1) Research ... the American Society of Hematology highlights intriguing studies ... presents for children with this blood disorder, evaluations ...
(Date:12/6/2009)... 6, 2009 A new study provides welcome news ... venous thromboembolism (VTE). , The condition is estimated ... and occurs when an abnormal clot forms in a ... and swelling. In some cases, the clot may detach ... heart to the lungs, causing a potentially fatal condition ...
(Date:12/6/2009)... organizations and members of the community, in cooperation with the Greater ... a holiday party. This year,s attendance is expected to soar to ... , ... (PRWEB) December 6, 2009 -- Volunteer ... VA Healthcare System in West Los Angeles, will once again create ...
(Date:12/5/2009)... new three-drug combination has shown in a phase 1/2 ... regimen" in the treatment of patients newly diagnosed with ... bone marrow, say researchers from Dana-Farber Cancer Institute. , ... the 66 patients treated with the drug combination in ... good partial response rate" in the phase 2 population, ...
Breaking Medicine News(10 mins):Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2
... BETHESDA, Md., Feb. 3 The American College of Medical ... www.acmgfoundation.org . "The new ACMG Foundation website is not ... is but also to see first-hand how the initiatives of ... health through the translation of genetic discoveries into better patient ...
... the drug treatment of cancer pain in 2008 is valued ... released today by WWMR, Inc. The cancer pain market is ... the next decade. The increasing number of cancer pain ... the forecast period. Few of the many drugs in ...
... ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), ... Executive Officer, will present an update on the Company,s ... CEO & Investor Conference at 11:00 a.m. Eastern Time ... access the live audio broadcast or the subsequent archived ...
... , , TUESDAY, Feb. 3 (HealthDay News) -- Mammography use has ... to a new study from the U.S. Centers for Disease ... mammography use increased slightly from 2000 to 2006 in 17 ... fell by 0.3 to 5.3 percent in the 34 states ...
... 5%, study found , , TUESDAY, Feb. 3 (HealthDay News) -- ... of the deadly skin cancer melanoma later in life, a ... born in 1998 in Colorado, asking their parents about childhood ... were age 7 to look for nevi -- commonly known ...
... Volunteers play a critical role in world,s largest ... the coming months, hundreds of Rotary club members ... Korea, the United Kingdom and the Caribbean will ... volunteers and health workers to immunize children against ...
Other Medicine News:Health News:American College of Medical Genetics Foundation Unveils New Website: ACMG Foundation Supports Medical Genetics Research, Education and Practice 2Health News:US Cancer Pain Market to Reach $5 Billion by 2018 - Cancer Patient Growth Drives Value 2Health News:US Cancer Pain Market to Reach $5 Billion by 2018 - Cancer Patient Growth Drives Value 3Health News:Fewer Women Are Having Mammograms 2Health News:Childhood Beach Vacations May Boost Melanoma Risk 2Health News:Rotary Members Worldwide Prepare For Mass Immunization Campaigns In Polio-Endemic Countries 2Health News:Rotary Members Worldwide Prepare For Mass Immunization Campaigns In Polio-Endemic Countries 3
(Date:12/4/2009)... Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary ... the initial development and successful testing of a novel ... believes this proprietary optical engine design raises the bar ... designs for swept source OCT light sources. This ...
(Date:12/4/2009)... Drs. Neal Shore and E. David Crawford presented ... analysis of secondary end points of biochemical recurrence rate ... degarelix for injection) or monthly leuprolide in prostate cancer ... cancer patients who received FIRMAGON 240/80 mg/month had a ...
(Date:12/3/2009)... Global, LLC , a leading primary research firm, today announced ... data release that monitors and projects trends and market share ... Apnea Tracker captures actual patient usage for 87 different Sleep ... different equipment providers going back to January 2006. In ...
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 60750 1TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 60750 2TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 60750 3TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 60750 4LenSar 3A New Laser Cure for Cataracts 6005 1LenSar 3A New Laser Cure for Cataracts 6005 2Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 1Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 2Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 3Oso Healthcare Provides Implementation and Support Services for ClearCanvas Open Source RIS PACS 60748 4
... WASHINGTON, Oct. 26 Today Senator Hillary,Clinton pledged that, ... range,of bold, new policies to address global HIV/AIDS, the ... Religious and community leaders belonging to two local groups, ... asked that she sign a,"Presidential Pledge for Leadership on ...
... From Open-Label Follow-up Include Longer-term Safety ... ... Oct. 26 Adults with Attention Deficit,Hyperactivity Disorder (ADHD) treated ... symptom management compared to adults taking placebo,according to study results ...
Other Medicine Technology:Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty 2New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo 2New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo 3New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: